Physician

James E Honet, M.D.

According to 2025 Medicare claims, James Honet, M.D. (NPI: 1093794224) practices interventional pain management (ipm) in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is NEURO PAIN CONSULTANTS PC (NPI: 1417936584; TIN: 383393457) and primary practice location at 48302-0305.

Honet's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 498 traditional Medicare patients, billed 8,850 HCPCS/CPT codes, and received $268,742 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 4,576 prescription claims across 691 beneficiaries totaling $206,512 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 62 records totaling $1,471. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $371,190 to $268,742. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $517,081 to $206,512. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	778	21,078	$371,190
2016	925	8,204	$448,017
2017	898	7,653	$419,627
2018	805	9,025	$420,376
2019	773	9,216	$409,779
2020	595	6,629	$365,199
2021	622	6,879	$383,593
2022	603	6,982	$323,615
2023	521	7,476	$292,880
2024	498	8,850	$268,742

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	617	5,208	$517,081
2016	682	4,432	$388,433
2017	733	4,215	$314,258
2018	681	4,429	$315,162
2019	705	4,420	$272,243
2020	604	4,470	$216,523
2021	598	4,093	$197,473
2022	644	4,249	$228,929
2023	639	4,378	$201,498
2024	691	4,576	$206,512

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	85	166	$194
62323	Injection of substance into lower spine canal using imaging guidance	115	141	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	236	829	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	197	353	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	714	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	79	2,295	$40,001
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,246	36,188	$23,745
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	610	17,727	$14,879
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	73	2,123	$13,878
Fentanyl	Fentanyl	161	4,933	$13,638

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,471	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James E. Honet, M.D.?

Tedicare shows public-source Medicare data for James E. Honet, M.D. (NPI 1093794224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James E. Honet, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James E. Honet, M.D.?

James E. Honet, M.D. is linked to NEURO PAIN CONSULTANTS PC (billing NPI 1417936584) in the available physician profile data.

Does James E. Honet, M.D. have Open Payments data?

James E. Honet, M.D. has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.